The FDA endorsed a ≥2-point reduction on a visual analogue scale for pain as a clinically meaningful endpoint for urcosimod ...

OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye ...

Chronic pain affects over 50 million adults in the U.S. alone and is a leading cause of disability worldwide (Dahlhamer et al., 2018). Yet not all chronic pain is the same, and understanding what kind ...

Depending on the cause, nerve pain can become chronic, but there are many mediation options that can help. Nerve pain, also known as neuropathic pain, can come in various forms, from stabbing and ...

There is no clear evidence that cannabis-based medicines provide pain relief for chronic neuropathic pain, an updated review ...

Analyzing molecular changes in two types of peripheral nerves that are affected in diabetic peripheral neuropathy – the sural, which carry sensory signals, and the tibial, which carry both sensory and ...

Neuropathic pain is nerve pain coming from malfunctions of or damage to the nervous system (brain, spinal cord, peripheral nerves). It is different from pain messages that are carried along healthy ...

Nerve pain affects millions of people worldwide, creating a burning, shooting, or electric sensation that can make daily activities nearly impossible. Unlike regular pain that responds well to common ...

A comprehensive review of clinical trials finds little convincing evidence that cannabis-based medicines provide real relief for chronic nerve pain.